LncRNA FOXD3-AS1 mediates AKT pathway to promote growth and invasion in hepatocellular carcinoma through regulating RICTOR

C Liu, M Zhang, J Zhao, X Zhu, L Zhu… - Cancer Biotherapy & …, 2020 - liebertpub.com
Background: Hepatocellular carcinoma (HCC) has high morbidity and mortality, but current
therapeutic methods cannot effectively improve patient's prognosis. FOXD3-AS1, a new …

Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues

H Liang, J Zhang, C Shao, L Zhao, W Xu… - Journal of Experimental …, 2012 - Springer
Background RNA binding motif 5 (RBM5) is a tumor suppressor gene that modulates
apoptosis through the regulation of alternative splicing of apoptosis-related genes. This …

Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway

Y Tian, L Shen, F Li, J Yang, X Wan… - Journal of cellular …, 2020 - Wiley Online Library
Colorectal cancer (CRC) is commonly known as one of the most prominent reasons for
cancer‐related death in China. Ras homolog enriched in brain (RHEB) and the mammalian …

[HTML][HTML] Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features

J Peng, AK Valeshabad, Q Li… - Oncology …, 2013 - spandidos-publications.com
Abstract RNA binding motif 5 (RBM5) is a tumor suppressor gene that regulates cell
proliferation, differentiation and apoptosis through pre-mRNA splicing of related genes. This …

RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma

L Zhang, Y Zhang, D Shen, Y Chen, J Feng… - Journal of …, 2022 - Taylor & Francis
Purpose RNA binding motif protein 3 (RBM3) has been reported to be dysregulated in
various cancers and associated with tumor aggressiveness. Epithelial–mesenchymal …

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells

Y Murakami, K Sugiyama, H Ebinuma, N Nakamoto… - BMC cancer, 2018 - Springer
Background We previously showed that knockdown of nuclear factor E2-related factor 2
(Nrf2) resulted in suppression of hepatitis C virus (HCV) infection. In this study, whether …

[HTML][HTML] Inhibition of RFX6 suppresses the invasive ability of tumor cells through the notch pathway and affects tumor immunity in hepatocellular carcinoma

M Song, M Kuerban, L Zhao, X Peng, Y Xu - Frontiers in Oncology, 2021 - frontiersin.org
Background The DNA-binding protein RFX6 was overexpressed in hepatocellular
carcinoma, and its expression level was correlated with the prognosis and immune cell …

Silencing RPL8 inhibits the progression of hepatocellular carcinoma by down-regulating the mTORC1 signalling pathway

T Sun, W Zhu, Q Ru, Y Zheng - Human cell, 2023 - Springer
This study aimed to explore the role of ribosomal protein L8 (RPL8) in controlling
hepatocellular carcinoma (LIHC) development. We measured RPL8 expression, apoptosis …

[HTML][HTML] Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells

MM Yu, YH Feng, L Zheng, J Zhang… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common malignant
tumors with high mortality-to-incidence ratios. Nuclear factor erythroid 2-like 3 (NFE2L3) …

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy

J Chen, L Liu, J Xu - OncoTargets and therapy, 2017 - Taylor & Francis
RNA-binding motif 4 (RBM4) has been reported to play an important role in many human
tumors such as lung cancer, breast cancer, ovarian cancer and gastric cancer by regulating …